Sartorius Stedim Biotech SA
PAR:DIM
Relative Value
The Relative Value of one
DIM
stock under the Base Case scenario is
211.99
EUR.
Compared to the current market price of 170.8 EUR,
Sartorius Stedim Biotech SA
is
Undervalued by 19%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
DIM Competitors Multiples
Sartorius Stedim Biotech SA Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
16.6B EUR | 5.9 | 65.2 | 22.7 | 37.3 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 366.4 | 4 338.6 | 1 375.6 | 2 939.1 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
188.8B USD | 4.2 | 28.2 | 19.7 | 26.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
145.3B USD | 5.9 | 40.2 | 22.3 | 33.9 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
79.2T KRW | 8.4 | 29 | 29.1 | 38.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
36.6B CHF | 5.7 | 39.1 | 28.7 | 28.7 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
291.5B CNY | 6.6 | 19.4 | 19.7 | 19.7 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
35.1B USD | 5 | 26.9 | 19.7 | 23.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.9B USD | 1.7 | 20.5 | 11.5 | 17.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.6B USD | 6.9 | 31.8 | 23.4 | 26 | |
| CN |
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
164.8B HKD | 7.3 | 34.8 | 24.4 | 24.4 |